Loading company…
Riskpilot
← Back to search
Sign in
Get full access
CYTOX AS
AS
Active
Org 911090562
Nedre Nøttveit 58, 5238 Rådal
Skadedyrkontroll · NACE 81291
Est. 1927
13 employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2021
NOK 15M
+5% vs 2020
EBITDA margin
8.8%
-31% vs 2020
Equity ratio
19.9%
Financial strength
Net profit 2021
NOK 942K
-32% vs 2020
EBITDA — year on year
NOK millions
4M
3M
2M
1M
0M
3M
2017
2M
-33%
2018
1M
-50%
2019
2M
+100%
2020
1M
-50%
2021
Key figures
Annual report 2021
Revenue
NOK 15M
+5%
EBITDA
NOK 1,3M
-31%
Net profit
NOK 942K
-32%
Total assets
NOK 7,9M
-1%
Equity
NOK 1,6M
-4%
Employees
13
—
Company information
Legal name
CYTOX AS
Org number
911090562
Legal form
Aksjeselskap
NACE code
81291 · Skadedyrkontroll
Founded
23. november 1927
Share capital
NOK 100 000
Employees
13 (FTE)
VAT registered
No
Audit selected
No
Last report
2021-12-31
Financial year
January – December
Company purpose
Yte tjenester i forbindelse med fast eiendom.
Contact
Address
Nedre Nøttveit 58, 5238 Rådal
Phone
+4755302400
Email
firmapost@cytox.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Skadedyrkontroll
Companies in Bergen
All Norway companies
Revenue
NOK millions
0M
4M
9M
13M
17M
15M
2017
15M
2018
15M
2019
14M
2020
15M
2021
EBITDA
NOK millions
0M
1M
2M
3M
3M
3M
2017
2M
2018
1M
2019
2M
2020
1M
2021
Income statement
NOK thousands
Item
2017
2018
2019
2020
2021
Revenue
15 097
14 516
14 679
14 301
14 952
Staff expenses
−7 044
−7 321
−8 619
−8 304
−9 520
EBITDA
2 520
2 114
1 421
1 918
1 318
Depreciation & amort.
−145
−135
−128
−143
−111
EBIT
2 375
1 979
1 294
1 775
1 208
Net financials
16
47
20
8
0
Profit before tax
2 391
2 027
1 314
1 783
1 208
Tax
550
471
289
392
266
Net profit
1 841
1 556
1 025
1 391
942
Balance sheet
NOK thousands
Item
2017
2018
2019
2020
2021
Total assets
7 995
7 530
8 132
7 960
7 858
Equity
1 451
1 507
1 531
1 623
1 564
Long-term debt
188
137
326
215
142
Short-term debt
6 356
5 887
6 275
6 123
6 152
Total debt
6 544
6 024
6 601
6 338
6 294
Financial ratios
5-year trend
EBITDA margin
8.8%
This company
15.8%
Market median
-44% vs market
2017
2021
Equity ratio
19.9%
This company
38.2%
Market median
-48% vs market
2017
2021
Return on equity
60.2%
This company
18.4%
Market median
+227% vs market
2017
2021
Net profit margin
6.3%
This company
8.1%
Market median
-22% vs market
2017
2021
Asset turnover
1.90×
This company
1.12×
Market median
+70% vs market
2017
2021
Debt / equity
4.02×
This company
0.62×
Market median
-548% vs market
2017
2021
Annual reports & filings
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
View
PDF
Annual report 2019
Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
View
PDF
Annual report 2018
Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
View
PDF
Annual report 2017
Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (1)
HI
Helge Ivarsøy
Chief Executive Officer
Chief Executive Officer
1989
Board of directors
Non-executive oversight
Name
Role
Member since
Current (1)
PI
Pål Ivarsøy
Chairman
2002
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of CYTOX AS also hold positions in
0
other companies.
Person
Role here
Other companies
Helge Ivarsøy
Chief Executive Officer
0 companies
Pål Ivarsøy
Chairman
0 companies